alcian-blue and Angina-Pectoris

alcian-blue has been researched along with Angina-Pectoris* in 1 studies

Other Studies

1 other study(ies) available for alcian-blue and Angina-Pectoris

Article	Year
[Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease]. Terapevticheskii arkhiv, 1987, Volume: 59, Issue:7 It was shown that fructose-1.6-diphosphate was capable of marked suppression of the aggregation power of the blood erythrocytes of patients with acute myocardial infarction and angina of effort. The antiaggregation effect of the drug was dose-related and enhanced with an increase in the time of its contact with erythrocytes. The antiaggregation effect of pentoxifylline was not of distinct dose-related nature. Its antiaggregation power did not considerably depend on the time of incubation with erythrocytes. Topics: Adult; Aged; Alcian Blue; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Aggregation; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged; Myocardial Infarction; Pentoxifylline; Theobromine	1987

Article

Year

[Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].

Terapevticheskii arkhiv, 1987, Volume: 59, Issue:7

It was shown that fructose-1.6-diphosphate was capable of marked suppression of the aggregation power of the blood erythrocytes of patients with acute myocardial infarction and angina of effort. The antiaggregation effect of the drug was dose-related and enhanced with an increase in the time of its contact with erythrocytes. The antiaggregation effect of pentoxifylline was not of distinct dose-related nature. Its antiaggregation power did not considerably depend on the time of incubation with erythrocytes.

Topics: Adult; Aged; Alcian Blue; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Aggregation; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged; Myocardial Infarction; Pentoxifylline; Theobromine

1987